Social Sentiment Ticker Powered by AI

DOW/USDDow Jones Industrial Average/USD
38,778.10
0.00
bearish
SPX/USDStandard & Poor’s 500/USD
5,473.23
0.00
bearish
NDX/USDNASDAQ Composite/USD
17,857.02
0.00
bearish
BTC/USDBitcoin – United States Dollar/USD
65,755.25
-727.00(1.09%)
bearish
ETH/USDEthereum – United States Dollar/USD
3,448.25
-61.60(1.76%)
bearish
XRP/USDRipple – United States Dollar/USD
0.50
-0.00(0.89%)
bearish
DOGE/USDDogecoin – United States Dollar/USD
0.12
-0.01(4.71%)
bearish
AAPL/USDApple Inc./USD
217.25
+0.58(0.27%)
bullish
GOOGL/USDAlphabet Inc. Class A Common Stock/USD
177.48
+0.24(0.14%)
bullish
TSLA/USDTesla, Inc. Common Stock/USD
188.18
+0.74(0.39%)
bullish
META/USDMeta Platforms, Inc. Class A Common Stock/USD
505.60
-1.03(0.20%)
bearish
NVDA/USDNvidia Corp/USD
131.29
+0.31(0.23%)
bullish
AMD/USDAdvanced Micro Devices/USD
157.88
-0.53(0.33%)
bearish
COIN/USDCoinbase Global, Inc. Class A Common Stock/USD
241.38
-3.72(1.52%)
bearish
NFLX/USDNetFlix Inc/USD
676.32
+0.49(0.07%)
bullish

Social Sentiment Ticker Powered by AI

DOW/USDDow Jones Industrial Average/USD
38,778.10
0.00
bearish
SPX/USDStandard & Poor’s 500/USD
5,473.23
0.00
bearish
NDX/USDNASDAQ Composite/USD
17,857.02
0.00
bearish
BTC/USDBitcoin – United States Dollar/USD
65,755.25
-727.00(1.09%)
bearish
ETH/USDEthereum – United States Dollar/USD
3,448.25
-61.60(1.76%)
bearish
XRP/USDRipple – United States Dollar/USD
0.50
-0.00(0.89%)
bearish
DOGE/USDDogecoin – United States Dollar/USD
0.12
-0.01(4.71%)
bearish
AAPL/USDApple Inc./USD
217.25
+0.58(0.27%)
bullish
GOOGL/USDAlphabet Inc. Class A Common Stock/USD
177.48
+0.24(0.14%)
bullish
TSLA/USDTesla, Inc. Common Stock/USD
188.18
+0.74(0.39%)
bullish
META/USDMeta Platforms, Inc. Class A Common Stock/USD
505.60
-1.03(0.20%)
bearish
NVDA/USDNvidia Corp/USD
131.29
+0.31(0.23%)
bullish
AMD/USDAdvanced Micro Devices/USD
157.88
-0.53(0.33%)
bearish
COIN/USDCoinbase Global, Inc. Class A Common Stock/USD
241.38
-3.72(1.52%)
bearish
NFLX/USDNetFlix Inc/USD
676.32
+0.49(0.07%)
bullish

Download App

Master the Markets with TradeZing PLUS’s AI Powered Tools

Learn More
Back

Advertisement

Live Audio Room

No related audio room.

Related Events

No related events.


Latest Feed


Related on Reddit


Related on X


Related on YouTube

0

November 21, 2023
7 months ago

Immix Biopharma Announces FDA Approval of IND Application for CAR-T NXC-201, Enabling U.S. Patient Dosing

LOS ANGELES, Nov. 21, 2023 (GLOBE NEWSWIRE) — Immix Biopharma, Inc. (Nasdaq:IMMX) (“ImmixBio”, “Company”, “We” or “Us”), a clinical-stage biopharmaceutical company advancing personalized therapies for oncology and immunology, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for BCMA CAR-T NXC-201 (formerly HBI0101). With this clearance, NEXICART-2 (NCT06097832) is to expand studies of NXC-201 in relapsed/refractory AL Amyloidosis to the United States. Favorable tolerability enables potential expansion into autoimmune indications.

Continue Reading

Feed Topics

News

Feed Tags

Advertisement

Subscribe

Notify of


0 Comments


Inline Feedbacks
View all comments

Copied